Public procurement notice: Contract Notice
Published: 2016-12-07
Buyer: University of Aberdeen
Country: UK
Region: Aberdeen City and Aberdeenshire
Contract type: Supplies
Procedure: Open procedure
CPV classification: 85121200: Specialist medical services
Submission deadline: 2017-01-10
Award criteria: The most economic tender

Technical requirements: University of Aberdeen requires a supplier to provide drug and placebo manufacture, packaging and dispatch to a central clinical trials pharmacy in Aberdeen for a 5-year period from February 2017. The estimated number of trial patients is 1 600.
ESPD Question 4A.2 — particular authorisation or membership of a particular organisation. The bidder must provide certified evidence that they are licensed and approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to provide all of the services required.
ESPD Section 4B — financial years — minimum levels of standards possibly required: all financial information must be provided for the most current previous 2 reported financial years.
ESPD Question 4B1.1 (minimum standards) Turnover should be up to twice the estimated contract value over the past 2 financial years. However, the client reserves the right to review and consider all supporting financial information in this regards.
During the term of the contract and for a period of 5 years thereafter, the supplier shall effect and maintain in force, with a reputable insurance company, a policy or policies of insurance covering all matters which are the subject of indemnities under the contract including Product Liability insurance to a minimum sum of 10 000 000 GBP and Employers Liability insurance to a minimum sum of 5 000 000 GBP, in each case in respect of any one incident and unlimited as to the number of incidents unless otherwise agreed by the client in writing. Where the contract relates to Professional Services, the supplier shall maintain in force with reputable insurers Professional Liability insurance in the sum not less than 5 000 000 GBP in respect of any one incident and unlimited as to numbers of claims. The client reserves the right to require adjustments to such insurance cover if they consider that to be necessary.
ESPD 4C.1.2 — Please provide relevant examples of similar services of a similar size and complexity during the last 3 years.
ESPD Question 4C.6 — bidder to confirm that each batch is released by a Qualified Person in accordance with current Good Manufacturing Practice Requirements and Directive 2001/20/EC of the European Parliament and of the Council.
ESPD Question 4C.12 — Bidder to provide Manufacturer's Authorisation for Investigational Medicinal Products and provide evidence that all services will be performed under the auspices of current Good Manufacturing Practice (GMP) derived from ‘The Rules governing Medicinal Products in the European Community, Good Manufacturing Practice for Medicinal Products.’(Eudralex volume 4).
Note: to register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at http://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=469323
The buyer has indicated that it will accept electronic responses to this notice via the Postbox facility. A user guide is available at http://www.publiccontractsscotland.gov.uk/sitehelp/help_guides.aspx
Suppliers are advised to allow adequate time for uploading documents and to dispatch the electronic response well in advance of the closing time to avoid any last minute problems.
Download the ESPD document here: http://www.publiccontractsscotland.gov.uk/ESPD/ESPD_Download.aspx?id=469323

Eligibility requirements: ESPD Question 4A.2 — particular authorisation or membership of a particular organisation. The bidder must provide certified evidence that they are licensed and approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to provide all of the services required.